NASDAQ:NPCE
NeuroPace, Inc. Stock News
$8.17
-0.390 (-4.56%)
At Close: May 17, 2024
NeuroPace, Inc. (NPCE) CEO Michael Favet on Q1 2023 Results - Earnings Call Transcript
07:42am, Sunday, 07'th May 2023
NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Favet - President & Chief Executive Officer, NeuroPace
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
04:05pm, Monday, 17'th Apr 2023
MOUNTAIN VIEW, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, to
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
04:05pm, Monday, 03'rd Apr 2023
MOUNTAIN VIEW, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, to
NeuroPace, Inc. (NPCE) Q4 2022 Earnings Call Transcript
10:21pm, Thursday, 02'nd Mar 2023
NeuroPace, Inc. (NASDAQ:NPCE ) Q4 2022 Results Conference Call March 2, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Favet - President, CEO & Director Rebecca Kuhn - CFO,
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
08:00am, Friday, 10'th Feb 2023
MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
04:03pm, Wednesday, 21'st Dec 2022
MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
Accelmed Partners Takes Activist Position in NPCE / Neuropace After Q3 Results
01:35am, Wednesday, 23'rd Nov 2022
Fintel reports that Accelmed Partners II L.P.
Neuropace, Inc. (NPCE) Q3 2022 Earnings Call Transcript
08:55pm, Saturday, 12'th Nov 2022
Neuropace, Inc. (NASDAQ:NPCE ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Philip Taylor - Gilmartin Group Michael Favet - President, CEO & Director Rebecca Kuhn
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
04:03pm, Friday, 04'th Nov 2022
MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
04:03pm, Tuesday, 25'th Oct 2022
MOUNTAIN VIEW, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
04:06pm, Tuesday, 23'rd Aug 2022
MOUNTAIN VIEW, Calif. , Aug. 23, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, to
NeuroPace, Inc. (NPCE) CEO Mike Favet on Q2 2022 Results - Earnings Call Transcript
06:45am, Saturday, 13'th Aug 2022
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Matt Bacso - Investor Relations Mike Favet - Chief Executive Officer Rebecca Kuhn - Chie
NeuroPace to Report Second Quarter 2022 Financial Results on August 11, 2022
04:03pm, Thursday, 21'st Jul 2022
MOUNTAIN VIEW, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, tod
NeuroPace, Inc.'s (NPCE) CEO Mike Favet on Q1 2022 Results - Earnings Call Transcript
10:47pm, Friday, 13'th May 2022
NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Matt Bacso – Investor Relations Mike Favet – Chief Executive Officer Rebecca Kuhn – C
NeuroPace to Present at the 2022 RBC Capital Markets Global Healthcare Conference
08:00am, Friday, 13'th May 2022
MOUNTAIN VIEW, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, t
